Our team of highly qualified scientists deliver preclinical research solutions - ranging from single cells and isolated in vitro tissue preparations from rodents, non-human primate and human, to the whole organism level. We work closely with our clients and tailor programs to the client's specific needs.
NeuroSolutions was founded to provide technically demanding electrophysiology to the biopharmaceutical industry. Our team of highly qualified scientists deliver preclinical research solutions - ranging from single cells and isolated in vitro tissue preparations from rodents, non-human primate and human, to the whole organism level. We work closely with our clients and tailor programs to the client's specific needs.
We are comfortable working on single fee-for-service contracts right up to multiple member research teams driving forward development programs under FTE agreements or as a working partnership. We incorporate the latest technologies in our pursuit of electrophysiological excellence and deliver exceptional results ahead of schedule and are able to provide animal behavioural and molecular biological services of the highest quality in parallel with our electrophysiological expertise.
NeuroSolutions Limited (“NeuroSolutions”) was founded and incorporated in 2001 as a “spin-out” company from the University of Warwick in the UK. NeuroSolutions is a neuroscience and neurology-based translational research and development company.
For nearly 25 years, NeuroSolutions has been a leading Contract Research Organisation (CRO) providing high quality electrophysiological services to the Pharmaceutical and Biotechnology industry, with management having a combined experience of over 100 years in electrophysiological research and drug development within this sector. The company was established to position itself as a leading provider of specialised electrophysiology services to the biopharmaceutical industry.
We use our technology to support all aspects of preclinical drug discovery and biomedical translational research with a particular focus on disease of the nervous system. The company supports research and development focused on pain, neurodegenerative and psychiatric disorders, anxiety, depression and central neural control of bodyweight, specifically obesity.
NeuroSolutions are able to offer our clients access to all aspects of preclinical electrophysiological research, from single cell to whole animals in tissues derived from rodents through to man, including non-human primates.
Single cells and isolated in vitro tissue preparations from rodents, non-human primate and human, to the whole organism level.
The company was established to position itself as a leading provider of specialised electrophysiology services to the biopharmaceutical industry.
We use our technology to support all aspects of preclinical drug discovery and biomedical translational research with a particular focus on disease of the nervous system.
"Thank you for the absolutely phenomenal work you have done for Redpin. As biotech managers, we frequently push CROs to the max and sometimes take them for granted. After reviewing the work that you have done over the past year, I felt that I needed to let you know what a difference you had made to Redpin’s growth and success. Your work has been of the highest caliber and your dedication unmatched."
Elma Hawkins PhD, MBA, former President and CEO Redpin Therapeutics, Inc.
"I have worked with NeuroSolutions on many projects over many years. The quality of the data is second to none, their scientific expertise and collaborative approach to our technicality demanding projects has been excellent. For example, the work on SEN1576 has led to high-impact joint publications with Senexis and this compound is now being developed by Talisman Therapeutics.."
Dr Mark Treherne - As former Chief Executive of Senexis Limited (Dr Treherne is currently Chief Executive of Life Sciences Organisation at UK Trade & Investment, which helps UK business trade overseas).
Email: info@nsolns.com
Contact Head-office on +44 (0) 8454 500171
One of our partner companies may be better suited to your requirements